Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Multiple Myeloma 21 Burkitt Lymphoma 20 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma 18 Leukemia, Myeloid, Acute 16 Neoplasms 15 Lymphoma, Follicular 15 Lymphoma, Non-Hodgkin 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Breast Neoplasms 12 Recurrence 10 Melanoma 10 Hodgkin Disease 10 Myelodysplastic Syndromes 9 Ovarian Neoplasms 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, B-Cell 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Hematologic Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Pancreatic Neoplasms 6 Sarcoma, Ewing 5 Sarcoma 5 Rhabdomyosarcoma 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Triple Negative Breast Neoplasms 4

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡